State of Montana gives broad regulatory approval for 3DCP Construction 3D Printing

by Architecture

Building code regulators at the US state level in Montana have made history as the first to approve 3D printed walls as an equal replacement for walls made with concrete masonry units (CMUs), or a standard cored concrete block. The approval was granted to Tim Stark, a contractor based in Billings, Montana, after filing documents, specifications, and testing reports developed by Apis Cor, the Florida-based construction technology company that holds the Guinness World Record for the largest (volume) 3D printed building globally.

f0cd9e518422770503891b827234ddc2.jpg

Geeetech launches its high-speed THUNDER FDM 3D printer Decision Makers

by Technologies

According to Geeetech, many consumer FDM printers, that are currently available on the market, are quite slow – which is the angle the company is using when marketing its new THUNDER high-speed 3D printer, which is expected to launch by early September, on Kickstarter (for early birds). Geeetech’s THUNDER 3D printer will come with a notably high printing speed, an all-metal body design, a “super strong cooling system”, and a large printing volume.

Braskem partners with Xenon arc to launch Braskem3D AM Industry

by Business

Xenon arc and Braskem, the largest polyolefins producer in the Americas and a market leader and pioneer producer of biopolymers on an industrial scale, have launched Braskem3D – an advanced direct-to-consumer technology platform that greatly simplifies and accelerates the accessibility of Braskem’s 3D materials to the North American market. This latest innovation will provide a strategic platform for growth to help support the growing demand for the company’s unique line of sustainable and innovative products.

a297f5a912797bb11771fd59f6238a56.jpg

Prellis Biologics appoints new CEO and raises $35 million Bioprinting

by Medical

Prellis Biologics, a biotherapeutics company utilizing its proprietary, high-resolution bioprinting technology to recreate and engineer human tissues in vitro, has appointed Michael Nohaile, PhD as its new CEO, and has raised a $35 million Series C funding round, co-led by Celesta Capital and Avidity Partners with participation from Khosla Ventures, SOSV, True Ventures, and Lucas Venture Group. Dr. Michael Nohaile joins the company from Generate Biomedicines and succeeds Prellis Biologics founder Dr. Melanie Matheu, who will assume the role of Chief Technology Officer and retain a Board seat.